These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37249604)

  • 1. The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma.
    Shi L; Chen H; Chen K; Zhong C; Song C; Huang Y; Wang T; Chen L; Li C; Huang A; Qi S; Li H; Lu Y
    Clin Cancer Res; 2023 Aug; 29(16):3172-3188. PubMed ID: 37249604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy.
    Noack J; Choi J; Richter K; Kopp-Schneider A; Régnier-Vigouroux A
    Cell Death Dis; 2014 Sep; 5(9):e1425. PubMed ID: 25255218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain.
    Yang FC; Wang C; Zhu J; Gai QJ; Mao M; He J; Qin Y; Yao XX; Wang YX; Lu HM; Cao MF; He MM; Wen XM; Leng P; Cai XW; Yao XH; Bian XW; Wang Y
    Lab Invest; 2022 Jul; 102(7):741-752. PubMed ID: 35351965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma.
    Yu J; Gao G; Wei X; Wang Y
    BMC Cancer; 2022 Jul; 22(1):786. PubMed ID: 35850753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation.
    Su IC; Su YK; Setiawan SA; Yadav VK; Fong IH; Yeh CT; Lin CM; Liu HW
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorpromazine overcomes temozolomide resistance in glioblastoma by inhibiting Cx43 and essential DNA repair pathways.
    Matarrese P; Signore M; Ascione B; Fanelli G; Paggi MG; Abbruzzese C
    J Transl Med; 2024 Jul; 22(1):667. PubMed ID: 39026284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma.
    Miao Z; Xu L; Gu W; Ren Y; Li R; Zhang S; Chen C; Wang H; Ji J; Chen J
    Redox Biol; 2024 Jul; 73():103220. PubMed ID: 38838551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance.
    Hwang YK; Lee DH; Lee EC; Oh JS
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOCS5 contributes to temozolomide resistance in glioblastoma by regulating Bcl-2-mediated autophagy.
    Yu J; Han L; Yang F; Zhao M; Zhou H; Hu L
    Bioengineered; 2022 Jun; 13(6):14125-14137. PubMed ID: 35730472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide.
    Johannessen TC; Hasan-Olive MM; Zhu H; Denisova O; Grudic A; Latif MA; Saed H; Varughese JK; Røsland GV; Yang N; Sundstrøm T; Nordal A; Tronstad KJ; Wang J; Lund-Johansen M; Simonsen A; Janji B; Westermarck J; Bjerkvig R; Prestegarden L
    Int J Cancer; 2019 Apr; 144(7):1735-1745. PubMed ID: 30289977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochanin A Sensitizes Glioblastoma to Temozolomide by Inhibiting Autophagy.
    Dong Q; Wang D; Li L; Wang J; Li Q; Duan L; Yin H; Wang X; Liu Y; Yuan G; Pan Y
    Mol Neurobiol; 2022 Feb; 59(2):1262-1272. PubMed ID: 34981417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
    Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
    Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
    Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G
    J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro-RNA29b enhances the sensitivity of glioblastoma multiforme cells to temozolomide by promoting autophagy.
    Xu JX; Yang Y; Zhang X; Luan XP
    Anat Rec (Hoboken); 2021 Feb; 304(2):342-352. PubMed ID: 32275350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulated ferroptosis-related gene SQLE facilitates temozolomide chemoresistance, and invasion and affects immune regulation in glioblastoma.
    Yao L; Li J; Zhang X; Zhou L; Hu K
    CNS Neurosci Ther; 2022 Dec; 28(12):2104-2115. PubMed ID: 35962621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dopamine D2 Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma Cells.
    Weissenrieder JS; Reed JL; Green MV; Moldovan GL; Koubek EJ; Neighbors JD; Hohl RJ
    Pharmacology; 2020; 105(1-2):19-27. PubMed ID: 31645049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition.
    Liu T; Li A; Xu Y; Xin Y
    Oncol Rep; 2019 Mar; 41(3):1883-1892. PubMed ID: 30664175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis.
    Buccarelli M; Marconi M; Pacioni S; De Pascalis I; D'Alessandris QG; Martini M; Ascione B; Malorni W; Larocca LM; Pallini R; Ricci-Vitiani L; Matarrese P
    Cell Death Dis; 2018 Aug; 9(8):841. PubMed ID: 30082680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
    Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
    Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.